Cloverna
Business Services · 1-10 Employees
View Company Info for Free
Overview
Website
www.cloverna.comRevenue
$5.4 MillionIndustry
ZI Rank: 1
About Cloverna
Cloverna Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cloverna your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Cloverna has new funding data
Cloverna, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Cloverna is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Cloverna
Check if Cloverna has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Cloverna launches new products
Click to see if Cloverna had a recent Job posting/layoffs
Earning: See what the market has to say on Cloverna recently announced quarterly report
Recommended Actions
Find VP level buyers at Cloverna
Find 2 more new buyers
Company Profile Activity
Activity Insights
Cloverna is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cloverna is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cloverna.
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Cloverna
CLOVERNA specializes in RNA targeted drug discovery technology, focusing on exploring unknown RNA drug targets to bring new hope to patients. Their unique CRISPR-based technology allows for the identification of druggable RNA motifs, which have been largely overlooked in traditional drug development that primarily targets proteins. The company coll... Read More
